"Family Resilience And Mind-body Enhancement" (FRAME): A Randomised Controlled Trial (FRAME)
Effects of "Family Resilience And Mind-body Enhancement" (FRAME) - a Mind-body Intervention for Parents With Autistic Children: A Randomised Controlled Trial
The goal of this clinical trial is to learn if a family resilience and mind-body programme called "Family Resilience And Mind-body Enhancement" (FRAME) works to support families with autistic children. The main question it aims to answer is:
- What are the effectiveness and acceptability of FRAME for families with autistic children?
Researchers will compare FRAME to a waitlist group (participants who receive the programme after the study ends) to see if FRAME makes a difference.
Participants will:
- Attend six weekly 2-hour group sessions, each combining mind-body practices and family resilience concepts
- Practise mindfulness exercises at home between sessions
- Complete questionnaires before and immediately after the programme, and 3 months later
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前：Jojo Yan Yan Kwok, PhD
- 電話番号：852 3917 6644
- メール：jojoyyk@hku.hk
研究連絡先のバックアップ
- 名前：Tsz Ying Christine Ng, MSc
- 電話番号：852 6200 0023
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
Participants are eligible if they:
- identify as the primary caregiver of at least one child aged 6-12 with an ASD diagnosis from a psychologist, pediatrician, or psychiatrist;
- currently cohabit with the child;
- provide informed consent to participate; and
- understand and can communicate in Cantonese Chinese
Exclusion Criteria:
Individuals will be excluded if they
- have significant medical condition(s) rendering them incapable of participating in the study; or
- are currently receiving other therapist-led psychological intervention(s).
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的：Family Resilience And Mind-body Enhancement" (FRAME)
|
Family Resilience And Mind-body Enhancement (FRAME) is a parent-focused mind-body intervention designed for parents of autistic children. Across six weekly 2hr sessions, FRAME integrates mind-body practices - which have demonstrated efficacy among families with autistic children - with Walsh's three domains of family resilience, namely belief systems, organizational patterns and communication processes. The mind-body component will be adapted from MYmind - an established mindfulness-based intervention specifically developed for children with ASD/ADHD and their parents. Each session follows a standard format: a review on home practice, guided mind-body practices and structured group discussions and activities targeting each domain of family resilience. Session content progresses sequentially across the six sessions. Between sessions, participants are encouraged to practise daily using the workbook provided. |
|
介入なし：Waitlist control
Control group will undergo intervention after completing all assessments |
この研究は何を測定していますか？
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Parenting stress
時間枠：From baseline (T0) to the end of treatment at 6 weeks (T1)
|
Parenting Stress Index - Short Form (PSI-SF) |
From baseline (T0) to the end of treatment at 6 weeks (T1)
|
|
Parenting stress
時間枠：From baseline (T0) to the end of treatment at 18 weeks (T2)
|
Parenting Stress Index - Short Form (PSI-SF) |
From baseline (T0) to the end of treatment at 18 weeks (T2)
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Parental distress
時間枠：Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
21-item Depression Anxiety Stress Scale-21 (DASS-21) |
Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
|
Parental Well-being
時間枠：Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
5-item World Health Organization Well-Being Index (WHO-5) |
Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
|
Mindful parenting
時間枠：Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
31-item Interpersonal Mindfulness in Parenting Scale (IM-P) |
Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
|
Child emotional and behavioural and problems
時間枠：Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
Parent and teacher-report Strengths and Difficulties Questionnaire (SDQ) |
Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
|
Sibling emotional and behavioural problems (only for families with more than one child)
時間枠：Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
Parent-report Strengths and Difficulties Questionnaire (SDQ) |
Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
|
Parent-sibling relationship (only for families with more than one child)
時間枠：Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
Parent-report parent-child dysfunctional interaction subscale of PSI-SF |
Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
|
Parent-child relationship
時間枠：Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
Parent-child dysfunctional interaction subscale of PSI-SF |
Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
|
Marital satisfaction
時間枠：Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
3-item Kansas Marital Satisfaction Scale (KMS) |
Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
|
Family resilience
時間枠：Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
Walsh Family Resilience Scale (WFRS) |
Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
|
Family functioning
時間枠：Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
McMaster Family Assessment Device (FAD) |
Baseline (T0), 6 weeks (T1), 18 weeks (T2)
|
|
Intervention acceptability
時間枠：Assessed at T1 (immediately post-intervention)
|
A 4-item self-reported program evaluation measured on a 10-point scale, assessing: (a) easiness of the program contents, (b) usefulness of the treatment, (c) overall satisfaction, and (d) likelihood to recommend the treatment to others. Higher scores indicate greater acceptability. |
Assessed at T1 (immediately post-intervention)
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- EA260737
- RG2026/2027_A_16 (その他の助成金/資金番号：Alice Ho Miu Ling Nethersole Charity Foundation)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
The data supporting the findings of this study are available upon request from the principal investigator, Prof. Kwok. These data are not publicly available, as they contain information that could compromise the privacy of research participants.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。